Jambuwala Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 2017.
2017 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Jambuwala Pharmaceuticals Limited

Jambuwala Pharmaceuticals Limited, a active public limited company, was established on 17 August 2017 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100GJ2017PLC098725. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹6.10 Cr and a paid-up capital of ₹6.09 Cr.

It upholds a compliant status. Employing 37 professional, Its leadership includes Pranlal Bhailal Shah (Director), Rasilaben Pranlal Shah (Director), Kamal Pranlal Shah (Director). Past directors included Hiren Vijaykumar Doshi, Chintan Pranlal Shah, Rasilaben Pranlal Shah. It holds ₹10.60 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Subplot C-19,20,21,22, Gallops Ind. Park2, Nh-8A Ahmd-Rajkot Highway Chachrawadi Vasna, S, Anand, Ahmedabad, Gujarat, 382213.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100GJ2017PLC098725

  • Registration Number

    098725

  • Incorporation Date

    17 August 2017

  • Authorized Capital

    ₹6.10 Cr

  • Paid-Up Capital

    ₹6.09 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.10 Cr
  • Paid Up Capital ₹ 6.09 Cr
  • Company Age 8 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 10.60 Cr
  • Revenue Growth **** 66.03%
  • Profit Growth **** -67.75%
  • Ebitda **** 16.05%
  • Net Worth -38.18%
  • Total Assets **** 8.79%
Company report

Jambuwala Pharmaceuticals Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Jambuwala Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Jambuwala Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Pranlal Bhailal Shah Director 17 Aug 2017 Current
Rasilaben Pranlal Shah Director 17 Aug 2024 Current
Kamal Pranlal Shah Director 17 Aug 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2020 Past
Pramod Abcsdd Director 23 Aug 2021 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Jambuwala Pharmaceuticals.

Jambuwala Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 66.03% increase. The company also saw a substantial fall in profitability, with a 67.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 38.18%.

Jambuwala Pharmaceuticals revenue growth over time
Jambuwala Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 66.03%
*******
*******
*******
*******
Revenue from Operations
*******
 65.78%
*******
*******
*******
*******
Total Assets
*******
 8.79%
*******
*******
*******
*******
Profit or Loss
*******
 -67.75%
*******
*******
*******
*******
Net Worth
*******
 -38.18%
*******
*******
*******
*******
EBITDA
*******
 16.05%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Jambuwala Pharmaceuticals?

In 2024, Jambuwala Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹105,984,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Sidbi : 10.60 Cr
Latest Charge Details
Date Lender Amount Status
01 Mar 2019 Sidbi ₹10.60 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Jambuwala Pharmaceuticals?

Jambuwala Pharmaceuticals has a workforce of 37 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Jambuwala Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jambuwala Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Jambuwala Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Jambuwala Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Jambuwala Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.

  • Director Appointment

    The activity Rasilaben Pranlal Shah was appointed as a Director was appointed as a Director on 17 Aug 2024 & has been associated with this company since 1 year 7 months . was completed.

  • Charges

    The activity A charge with Sidbi of Rs. 10.60 Cr registered on 01 Mar 2019 with Charge ID 100251220 was modified on 28 Mar 2024. was completed.

  • Charges

    A charge with Sidbi amounted to Rs. 10.60 Cr with Charge ID 100251220 was registered on 01 Mar 2019. was recorded as a recent event.

  • Director Appointment

    The activity Pranlal Bhailal Shah was appointed as a Director was appointed as a Director on 17 Aug 2017 & has been associated with this company since 8 years 7 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Jambuwala Pharmaceuticals Limited?

The CIN of Jambuwala Pharmaceuticals Limited is U24100GJ2017PLC098725.

Where is Jambuwala Pharmaceuticals Limited headquartered?

Jambuwala Pharmaceuticals Limited is headquartered at Subplot C-19,20,21,22, Gallops Ind. Park2, Nh-8A Ahmd-Rajkot Highway Chachrawadi Vasna, S, Anand, Ahmedabad, Gujarat, 382213.

When was Jambuwala Pharmaceuticals Limited incorporated?

Jambuwala Pharmaceuticals Limited was incorporated on 17 August 2017.

Who are the current directors of Jambuwala Pharmaceuticals Limited?

The current directors of Jambuwala Pharmaceuticals Limited are

What is the primary industry of Jambuwala Pharmaceuticals Limited?

The primary industry of Jambuwala Pharmaceuticals Limited is Manufacturing.

Is Jambuwala Pharmaceuticals Limited a listed company?

Jambuwala Pharmaceuticals Limited is unlisted.

What is the capital structure of Jambuwala Pharmaceuticals Limited?

The authorized capital of Jambuwala Pharmaceuticals Limited is ₹6.10 Cr, and the paid-up capital is ₹6.09 Cr.

What is the compliance status of Jambuwala Pharmaceuticals Limited?

The compliance status of Jambuwala Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available